Michela Luciano,  Science Writer—

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg, where her research focused on the role of inflammation in Acute Myeloid Leukemia. With a deep passion for scientific communication, Michela transitioned into her first role as Scientific Writer in 2022. Outside of work, Michela is a passionate photographer. She enjoys mountain hikes, running, and spending as much time as possible outdoors.

Articles by Michela Luciano

Tralesinidase alfa ERT for Sanfilippo type B children put on fast track

Tralesinidase alfa, also known as TA-ERT, Spruce Biosciences’ investigational enzyme replacement therapy (ERT) for children with Sanfilippo syndrome type B, has received breakthrough therapy designation from the U.S. Food and Drug Administration (FDA). The designation is intended to speed up the development and review of treatments that show early evidence…